We recently reported [23, 24] that haNK cells, a stable NK cell line that expresses the high affinity CD16 receptor, have the ability to lyse human tumor cells endogenously and by ADCC mediated by anti-PD-L1 MAb and other IgG1 isotype anti-tumor antibodies [23, 24]. Here, CD274 is linked to neoplasm.